Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris

Sohag University72 enrolled

Overview

Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients \& the relation between metabolic syndrome in acne vulgaris and level of asprosin.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Acne Vulgaris

Interventions

serum asprosinDIAGNOSTIC_TEST

assessment of serum asprosin by a commercially available double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) kit.

Eligibility

Sex: MALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Acne vulgaris male patients (\>18 years) will be included. Exclusion Criteria: * Age \<18 years. * Females. * Patients with other inflammatory skin disorders. * Patients with associated systemic diseases. * Current or previous treatment with isotretinoin in the last 3 month ,anti-inflammatory drugs, systemic antibiotics, androgen or anti androgen therapy, and steroid therapy). * Patients known on treatment of diabetes, hypertension and dyslipidemia. * Athletes. * Patient refusal.

Locations (1)

Sohag University Hospital

Sohag, Egypt

Outcomes

Primary Outcomes

Assess serum asprosin level in male patients with acne vulgaris.

Time frame: 6 months

Central Contacts

Esraa A Hamoda, resident

CONTACT

01007911703 esraaabdelazeem@med.sohag.edu.eg

Soha H Aboeldahab, assisstant professor

CONTACT

01094235561

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.